Psychemedics Corporation (PMD)

Provides hair testing for drugs of abuse, focusing on workplace and pre-employment drug testing.

PMD Stock Quote

Company Report

Psychemedics Corporation specializes in drug testing services utilizing hair analysis, catering to clients across the United States, Brazil, and globally. The company employs mass spectrometry for both screening and confirmation of a wide range of drugs of abuse present in hair samples. These substances include cocaine, marijuana, PCP, amphetamines like ecstasy and Adderall, opiates such as heroin and oxycodone, synthetic cannabinoids like K2 and Spice, benzodiazepines including Xanax and Valium, as well as nicotine and Fentanyl. The testing provides quantitative data that approximates the amount of ingested drugs and offers historical insights into long-term usage patterns.

Psychemedics Corporation's clientele includes employers conducting applicant and employee drug testing, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug habits. By leveraging robust industry practices and advanced analytical techniques, the company ensures reliable and accurate results crucial for making informed decisions regarding drug use monitoring and intervention strategies.

Established in 1986 and headquartered in Acton, Massachusetts, Psychemedics Corporation has evolved as a leader in drug testing innovation. Its commitment to precision and comprehensive testing methodologies underscores its mission to provide reliable solutions that contribute to a safer and healthier society.

PMD EPS Chart

PMD Revenue Chart

Stock Research

HUDA DGII HUMA CUBI VMCA VLAT PWOD

PMD Chart

View interactive chart for PMD

PMD Profile

PMD News

Analyst Ratings